featured
Obeticholic Acid for Primary Sclerosing Cholangitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Randomized, Placebo-Controlled, Phase II Study of Obeticholic Acid for Primary Sclerosing Cholangitis
J. Hepatol. 2020 Mar 09;[EPub Ahead of Print], KV Kowdley, R Vuppalanchi, C Levy, A Floreani, P Andreone, NF LaRusso, R Shrestha, J Trotter, D Goldberg, S Rushbrook, GM Hirschfield, T Schiano, Y Jin, R Pencek, L MacConell, D Shapiro, CL BowlusFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.